However, it has also been reported that ACC inhibition might result in hypertriglyceridemia through decreasing polyunsaturated fatty acids which further led to SREBP1 induction and decreased PPARα and CPT1 activity [21]. The gene discussed is CPT1A; the disease is hypertriglyceridemia.